ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Abstract Number: 1723
    RA Flare Prediction via Machine Learning and Algorithm Based on SSDM Big Data
  • Abstract Number: 1702
    RA-Related Knowledge and Skills of Rheumatology Fellows Among 20 US Academic Institutions
  • Abstract Number: 0843
    Rab4A Activation Predisposes to Hepatitis in Spontaneous and Pristane-Induced Mouse Models of Systemic Lupus Erythematosus
  • Abstract Number: 0844
    Rab4A Regulates Glomerulonephritis and Tryptophan Metabolism in Sle1.2.3. Lupus-prone Mice via Recycling of CD98
  • Abstract Number: 0006
    Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Disease Patients Diagnosed with COVID-19 in the US: Data from the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
  • Abstract Number: 0042
    Racial and Ethnic Differences in a Multiple Biochemical Measure of Rheumatoid Arthritis Disease Activity
  • Abstract Number: 1017
    Racial and Ethnic Disparities in the Risk of Preterm Birth Among Women with Systemic Lupus Erythematosus or Rheumatoid Arthritis with Varying Reference Groups
  • Abstract Number: 0055
    Racial and Sex-based Disparities in Health Care Utilization: Eye Inflammation as a Paradigm
  • Abstract Number: 0433
    Racial Disparities and New SLE-Specific Predictors of Stroke and Ischemic Heart Disease in Patients with Lupus
  • Abstract Number: 1644
    Radiographic Exclusionary Findings During Screening for Three Phase III Trials of Subcutaneous Tanezumab in Patients with Moderate to Severe Hip or Knee Osteoarthritis
  • Abstract Number: 1231
    Radiographic Outcomes in Patients with Rheumatoid Arthritis Receiving Upadacitinib as Monotherapy or in Combination with Methotrexate: Results at 2 Years
  • Abstract Number: 1895
    Radiographic Progression in Patients with Axial Spondyloarthritis Under Treatment with TNF Inhibitors. Data from REGISPONSERBIO (Spanish Register of Biological Therapy in Spondyloarthritides)
  • Abstract Number: 1235
    Radiographic Progression of Structural Joint Damage over 5 Years of Baricitinib Treatment in Patients with Rheumatoid Arthritis: Results from RA-BEYOND
  • Abstract Number: 1105
    RANK-L Activity: Understanding the Pathogenesis of Erosive Osteoarthritis
  • Abstract Number: 1551
    Rapid Effect of Tofacitinib in Reducing US Joint and Tendon Inflammatory Lesions of RA Patients: Data from a 24 Weeks Longitudinal Study
  • Abstract Number: 0458
    Rapid Implementation of a Multidisciplinary COVID-19 Cytokine Storm Syndrome Task Force
  • Abstract Number: 1377
    Raynaud’s Phenomenon and Systemic Sclerosis in Post-9/11 Deployed Veterans Receiving Care Veterans Health Administration Care
  • Abstract Number: 1253
    Re-evaluation of the Extent of Lymphocytic Infiltration May Improve the Diagnostic Accuracy of Lip Biopsy in Primary Sjögren’s Syndrome (pSS)
  • Abstract Number: 1219
    Reaching Remission by IL-1 Inhibition in Rheumatoid Arthritis Patients with Type 2 Diabetes Improves the Glucose Homeostasis: Long-term Findings from TRACK Study, a Multicentre, Open-label, Randomised, Controlled Trial
  • Abstract Number: 0651
    Readmission Risk and Quality of Care in Patients Presenting to the Emergency Department with Gout Flares
  • Abstract Number: 1683
    Ready or Not? Measuring Readiness for Transition to Adult Care in Adolescents with JIA & jSLE
  • Abstract Number: 0227
    Real Life Severe Infections in Patients with Rheumatoid Arthritis on Treatment with Biological Therapy and JAK Inhibitors
  • Abstract Number: 1031
    Real World Treatment Patterns Among Patients with Psoriatic Arthritis Treated with Ixekizumab
  • Abstract Number: 0802
    Real-World DMARD Experience and Outcomes for Rheumatoid Arthritis Patients in Japan: Effectiveness
  • Abstract Number: 0803
    Real-World DMARD Experience and Outcomes for Rheumatoid Arthritis Patients in Japan: Safety
  • Abstract Number: 1381
    Real-World Mono-, Double and Triple Combination Treatment Patterns with Macitentan in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Evidence from the Combined OPUS/OrPHeUS Dataset
  • Abstract Number: 0812
    Real-World Utilization of Infliximab (IFX) and Its Biosimilars in Patients (Pts) with Rheumatoid Arthritis (RA) Since the First Biosimilar Approval in the US
  • Abstract Number: 0556
    Recent Use, Missed Doses and Discontinuation of Infliximab in New-users: Comparisons of Biosimilar and Originator Exposures
  • Abstract Number: 0452
    Recombinant Zoster Vaccine in Patients with Rheumatic Diseases: A Retrospective Study of 622 Patients
  • Abstract Number: 1088
    Recruitment Rates of Virtual Remote Research (Tele-Research) in Myositis
  • Abstract Number: 1186
    Red Cell Distribution Width and Absolute Lymphocyte Count Associate with Biomarkers of Inflammation and Subsequent Mortality in Rheumatoid Arthritis
  • Abstract Number: 1187
    Red Cell Distribution Width Is Associated with ASCVD Risk Score and CVD in RA After Initiation of Methotrexate
  • Abstract Number: 1048
    Reduced Decline in Forced Vital Capacity in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs) Treated with Nintedanib
  • Abstract Number: 1425
    Reduced Risk of Cardiovascular Diseases Events with Renal Transplantation in Granulomatosis with Polyangiitis in the United States: Data from the US Renal Data System
  • Abstract Number: 0456
    Reduced Risk of Serious Pneumococcal Infection up to 10 Years After Immunization with 7-valent Conjugated Pneumococcal Vaccine in Patients with Inflammatory Arthritis
  • Abstract Number: 1965
    Reducing Delays for Biologic Medication Approval in Outpatient Rheumatology
  • Abstract Number: 0952
    Reducing Immunogenicity of Pegloticase (RECIPE) with Concomitant Use of Mycophenolate Mofetil in Patients with Refractory Gout—a Phase II Double Blind Randomized Controlled Trial
  • Abstract Number: 1227
    Reduction in Peripheral CD19+ CD27- Naïve B Cells Is Associated with Clinical Remission in Patients with Rheumatoid Arthritis Receiving Combined Treatment with Methotrexate and TNF Inhibitors
  • Abstract Number: 0881
    Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis During Certolizumab Pegol Treatment: 96-Week Results from the C-VIEW Study
  • Abstract Number: 0187
    Regional and Widespread Patterns of Non-articular Pain Are Common at RA Diagnosis and Contribute to Poor Outcomes at 12 Months: A Prospective Study of Pain Patterns in Canadians with RA
  • Abstract Number: 1489
    Relation of Pain Mechanisms to Development of Knee Pain in Osteoarthritis: The Multicenter Osteoarthritis Study
  • Abstract Number: 0563
    Relation of Pain Sensitization to Isokinetic Knee Extension Torque: The MOST Study
  • Abstract Number: 1037
    Relationship Between Air Quality and Sarcoidosis Inflammatory Activity
  • Abstract Number: 1211
    Relationship Between Changes in Lipid Levels and Improvement in Disease Activity Outcomes in Patients with Rheumatoid Arthritis Receiving Upadacitinib Treatment: Pooled Analysis of Data from Two Phase 3 Studies
  • Abstract Number: 1600
    Relationship Between Electronic Health Record Vendor and Performance on Patient-reported Outcome Quality Measures in the ACR’s Rheumatology Informatics System for Effectiveness (RISE) Registry
  • Abstract Number: 0484
    Relationship Between Paraoxonase-1 Genotype, Activity, and Major Adverse Cardiovascular Events in Patients with Rheumatoid Arthritis Receiving Tofacitinib
  • Abstract Number: 0491
    Relationship Between Rheumatoid Arthritis and Pulmonary Function in the UK Biobank
  • Abstract Number: 1020
    Relationship Between Skin-related Quality of Life, Psychosocial Stress, and Race in Cutaneous Lupus Erythematosus
  • Abstract Number: 1112
    Relationship of Depth-Specific Subchondral Bone Mineral Density and Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
  • Abstract Number: 1337
    Relationship of the Pro12Ala Polymorphism of the PPARg Gene with Inflammatory Activity, Osteoporosis and Obesity in Patients with Psoriatic Arthritis
  • Abstract Number: 0694
    Relationships Among Adherence and Patient Outcomes in a Cognitive Behavioral Plus Physical Activity Intervention for Older Adults with Osteoarthritis and Hypertension
  • Abstract Number: 0158
    Relationships Between Disease Patterns in RA and Rheumatology Treatment
  • Abstract Number: 1872
    Relative Associations of Sociodemographic, Clinical and HLA-B Alleles with Enthesitis and Peripheral Arthritis in Patients with Ankylosing Spondylitis
  • Abstract Number: 0943
    Reliability and Validity Issues in Fibromyalgia Diagnosis
  • Abstract Number: 1168
    Reliability and Validity of a New Skin Activity Measure for Localized Scleroderma
  • Abstract Number: 1889
    Reliability and Validity of the PROMIS-29 Health Profile in Ankylosing Spondylitis Patients
  • Abstract Number: 1132
    Reliability of Virtual Sources of Education for Patients with Vasculitis
  • Abstract Number: 1375
    Remission in Axial Spondyloarthritis: Is There a Difference Between NSAIDs and Biologics in the Real Life?
  • Abstract Number: 1710
    Remote Rheumapalooza: Reboot of a Foundational Rheumatology Curriculum for Pre-Clinical Medical Students in the Era of Virtual Learning
  • Abstract Number: 1672
    Renal Activity Index for Lupus Nephritis Distinguishes Active Renal Disease Among Childhood Systemic Lupus Erythematosus Patients
  • Abstract Number: 0686
    Renal Evolution During the First Year of Urate-lowering Therapy According to Sonographic Joint Deposition: Data from the Lille-Alicante Inception Cohort
  • Abstract Number: 1515
    Renal Responder Status and Associated Clinical Variables in the Lupus Accelerating Medicines Partnership Cohort
  • Abstract Number: 1791
    Renal Tubular Complement C9 Deposition Is Associated with Renal Tubular Damage and Fibrosis in Lupus Nephritis
  • Abstract Number: 0965
    Repetitive Inhalant Lipopolysaccharide Exposure in the Setting of Arthritis Induction Potentiates Pro-Fibrotic Inflammatory Lung Disease in Mice
  • Abstract Number: 1842
    Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus: Post Hoc Analyses of Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-blind, Placebo-Controlled Trial
  • Abstract Number: 0440
    Representation of Women as Authors of Rheumatology Research Articles
  • Abstract Number: 1786
    Reproductive Health Outcomes in Women with RA and PsA
  • Abstract Number: 2045
    Resident Memory T Cells in Synovial Tissue Mediate Arthritis Flares
  • Abstract Number: 1410
    Resident Memory T Cells Persist in Joints of Anakinra-Treated Mice in Spontaneous Arthritis Model
  • Abstract Number: 0909
    Residual Disease Activity in Psoriatic Arthritis Patients Treated with Secukinumab and Adalimumab Who Achieved Remission or Low Disease Activity: Results from a Phase 3b, Randomized, Double-blinded, Active-controlled, Head-to-head Study
  • Abstract Number: 0323
    Residual Symptoms in Patients with PsA Who Are in Very Low Disease Activity According to Physician Assessments
  • Abstract Number: 0863
    Residual Treatment Burden, Desired Improvement, and Prioritized Treatment Goals in Systemic Lupus Erythematosus (SLE): Results from the SLE-UPDATE (Understanding Preferences, Disease Activity and Treatment Expectations) Survey in the United States
  • Abstract Number: 1407
    Resolvin D5 Modulates Th17/Treg Cell Differentiation and Suppresses Osteoclastogenesis
  • Abstract Number: 2034
    Resolving Phenotypic and Prognostic Differences in Interstitial Lung Disease Related to Systemic Sclerosis by Computed Tomography-based Radiomics
  • Abstract Number: 0714
    Response to Abatacept in JIA Categories: Results from the PRCSG/PRINTO JIA Abatacept Phase IV Registry
  • Abstract Number: 0904
    Response to Ixekizumab by C-reactive Protein Level in Patients with Radiographic Axial Spondyloarthritis: Results from the COAST-V (Biological-Naïve) and COAST-W (TNF Inhibitor-Experienced) Trials at 52 Weeks
  • Abstract Number: 1554
    Response to Tocilizumab in Large Vessel Vasculitis According to the Extent of Baseline 18F-FDG Vascular Uptake
  • Abstract Number: 0361
    Response to Treatment with Ixekizumab in Patients with Active Non-Radiographic Axial Spondyloarthritis Based on HLA-B27 Status and Disease Duration
  • Abstract Number: 0869
    Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
  • Abstract Number: 0078
    Retrospective Analysis of Clinical Characteristics and Classification Criteria Performance in a Single Center Cohort of 114 Patients Diagnosed with IgG4-Related Disease
  • Abstract Number: 1141
    Reversing Seasonal Decline of T2T Outcome in RA Patients Under Double Hits by Chinese New Year and COVID-19 Epidemic via Online Interaction with SSDM
  • Abstract Number: 0093
    Review of Gastrointestinal Manifestations of Kohlmeier-Degos Disease
  • Abstract Number: 1586
    Rheum Service: Comprehensive Virtual Care During COVID-19
  • Abstract Number: 1177
    Rheumatic Diseases in Mexican Children and Their Psychosocial and Economic Impact on Caregivers
  • Abstract Number: 1759
    Rheumatoid Arthritis Affects the Ossicular Joints: A Human Otopathologic Study
  • Abstract Number: 1994
    Rheumatoid Arthritis Improvement After Exposure to an Anti-Inflammatory “ITIS” Diet Is Associated with Changes of Gut Microbiome and Systemic Metabolome
  • Abstract Number: 1761
    Rheumatoid Arthritis Inpatient Mortality: An Analysis of the National Inpatient Sample
  • Abstract Number: 0167
    Rheumatoid Arthritis Patient Phenotypes from a Digital Health Coaching Engagement Program
  • Abstract Number: 0567
    Rheumatologist’s Perception of the Efficacy, Safety and Willingness to Prescribe Infliximab and Use Alternate Drug Supply Programs to Lower Cost of Rheumatoid Arthritis Care
  • Abstract Number: 0061
    Rheumatologists’ Attitudes Toward Palliative Care and Medical Assistance in Dying
  • Abstract Number: 0477
    Rheumatology Fellowship Program Directors in the United States: Analysis of Demographics, Educational and Scholarly Achievements
  • Abstract Number: 0615
    Rheumatology Going Digital: Developing a Rheumatology App for Use by All Patients Attending Our Department to Aid Remote Working and Self-management
  • Abstract Number: 0636
    Rheumatology Patient Experience and Trends During the SARS-COV-2 Pandemic
  • Abstract Number: 0788
    Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery
  • Abstract Number: 1046
    Risk Factors Associated with Interstitial Lung Disease in Patients with RA: Findings from a Retrospective Healthcare Database Analysis
  • Abstract Number: 1694
    Risk Factors Associated with Pneumocystis Jirovecii Pneumonia in Juvenile Myositis in North America
  • Abstract Number: 1324
    Risk Factors for Adverse Pregnancy Outcomes in Women with Spondyloarthritis: An Observational Study from Two European Multidisciplinary Pregnancy Clinics
  • Abstract Number: 1775
    Risk Factors for Adverse Pregnancy Outcomes of Women with Positive for Antiphospholipid Antibodies Treated with Conventional Therapies
  • Abstract Number: 1825
    Risk Factors for Antimalarial-Induced Retinal Toxicity in Systemic Lupus Erythematosus and Other Rheumatic Diseases
  • Abstract Number: 1947
    Risk Factors for Anxiety and Depression in Patients with Giant Cell Arteritis
  • Abstract Number: 0561
    Risk Factors for Falls Among Individuals with Knee OA: A Longitudinal Community-based Study
  • Abstract Number: 0926
    Risk Factors for Fractures and Osteoporosis Among Patients with Systemic Sclerosis in a United States Cohort
  • Abstract Number: 0544
    Risk Factors for Lumbar Vertebral Osteoporosis Do Not Reflect Factors Traditionally Associated with Osteoporosis at the Hip
  • Abstract Number: 0670
    Risk Factors for Pseudogout: An Electronic Medical Record Case-Control Study
  • Abstract Number: 0579
    Risk Factors of Nonadherence in New Rheumatoid Arthritis Patients
  • Abstract Number: 1938
    Risk for Vision Loss and Relapse in Patients with Giant Cell Arteritis
  • Abstract Number: L02
    Risk Mitigating Behavior in People with Rheumatic Diseases or Psoriasis During the COVID-19 Pandemic Differ by Immunosuppressant Treatment Type: A Patient survey Study
  • Abstract Number: 0120
    Risk of Fracture in Patients with Different Glucocorticoid Requiring Diseases
  • Abstract Number: 0540
    Risk of Hydroxychloroquine Retinopathy in the Community
  • Abstract Number: 1001
    Risk of Malignant Melanoma and Nonmelanoma Skin Cancer in Rheumatoid Arthritis Patients Initiating Methotrexate versus Hydroxychloroquine
  • Abstract Number: 1005
    Risk of Non-vertebral Fractures Among Rheumatoid Arthritis Patients Treated with Biologic or Targeted-Synthetic DMARDs: A Multi-Database Comparative Safety Study
  • Abstract Number: 1417
    Risk of Relapse of ANCA-associated Vasculitis in Patients of 75 Years and Older: A Retrospective Study
  • Abstract Number: 0580
    Risk of Severe Acute Localized Reactions for Different Intra-Articular Hyaluronic Acid Knee Injections in a Real World Setting
  • Abstract Number: 2000
    Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Treated with Methotrexate versus Hydroxychloroquine
  • Abstract Number: 0650
    Risk of Vertebral Fractures at Lateral Chest Radiographies in Patients with Gout
  • Abstract Number: 1149
    Risk Score of Macrophage Activation Syndrome (MAS) in Patients with Systemic Juvenile Idiopathic Arthritis (sJIA)
  • Abstract Number: 1051
    Rituximab for Interstitial Pneumonia with Autoimmune Features at Two Academic Medical Centers
  • Abstract Number: 0527
    Rituximab for Refractory Manifestations of the Antiphospholipid Syndrome: A Multicenter Israeli Experience
  • Abstract Number: 1578
    Rituximab Hypersensitivity in Rheumatic and Inflammatory Diseases: Role of Skin Testing
  • Abstract Number: 1438
    Rituximab Immunogenicity in ANCA-associated Vasculitis (RITUXIMAV)
  • Abstract Number: 1050
    Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center
  • Abstract Number: 0287
    RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells
  • Abstract Number: 1547
    Role of Artificial Intelligence in Assessment of Peripheral Joint MRI in Inflammatory Arthritis: A Systematic Review and Meta-analysis
  • Abstract Number: 0783
    Role of Glutamine Metabolism in Rheumatoid Arthritis Fibroblast-Like Synoviocyte Aggressive Phenotype
  • Abstract Number: 0682
    Role of Inflammatory and Oxidative Stress Pathway Biomarkers in Renal Disease in Gout
  • Abstract Number: 0974
    Role of NR4A Nuclear Receptor Family in RA Synovial Ectopic Lymphoid Neogenesis Revealed by Single Cell Profiling
  • Abstract Number: 1513
    Role of Platelet C4d in Thrombosis and Lupus Nephritis
  • Abstract Number: 0290
    Role of Protein Tyrosine Phosphatase 1B (PTP1B) in Endothelial-to-Mesenchymal Transition (EndoMT) Promoted by Inflammation: Implications for SLE
  • Abstract Number: 0056
    Role of Socioeconomic and Cultural Factors in Racial Disparities in Disease Severity and Health Status of Patients with Axial Spondyloarthritis
  • Abstract Number: 1784
    Roles and Perspectives of Partners of Women with Rheumatoid Arthritis on Reproductive Decision Making: A Constructivist Grounded Theory Study
  • Abstract Number: 0101
    Romosozumab After Denosumab Improves Lumbar Spine and Maintains Total Hip Bone Mineral Density in Postmenopausal Women with Low Bone Mass
  • Abstract Number: 0139
    Routine Assessment of Patient Index Data (RAPID) 3 as a Predictor of Weight Reduction in Rheumatology Patients Undergoing Bariatric Surgery
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology